BIOMAT Database Logo BIOMAT Database Logo

Liver side effects associated with simvastatin therapy. 1991

J D England, and A Viles, and S Labib

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D019821 Simvastatin A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL. MK-733,Synvinolin,Zocor,MK 733,MK733

Related Publications

J D England, and A Viles, and S Labib
Simvastatin and side effects.
November 1991, The New Zealand medical journal,
J D England, and A Viles, and S Labib
Side effects associated with lithium therapy.
July 1979, Archives of general psychiatry,
J D England, and A Viles, and S Labib
Side effects associated with prostaglandin analog therapy.
November 2008, Survey of ophthalmology,
J D England, and A Viles, and S Labib
[Ocular side-effects associated with amiodarone therapy].
June 2005, Klinische Monatsblatter fur Augenheilkunde,
J D England, and A Viles, and S Labib
Undesirable side effects associated with prednisone therapy.
October 1956, Delaware state medical journal,
J D England, and A Viles, and S Labib
Not all side effects associated with tricyclic antidepressant therapy are true side effects.
April 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
J D England, and A Viles, and S Labib
Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.
May 1997, Southern medical journal,
J D England, and A Viles, and S Labib
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
October 2003, Southern medical journal,
J D England, and A Viles, and S Labib
Managing side effects associated with IL-2 therapy.
January 1990, Oncology nursing forum,
J D England, and A Viles, and S Labib
[Side-effects of glucocorticoids in liver therapy].
June 1969, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!